Racial and Ethnic Disparities in the Financial Burden of Prescription Drugs among Older Americans

Abstract

This study examines racial and ethnic disparities in the financial burden of prescription drugs among older Americans using a market and an egalitarian model. A nationally representative data set, the Medical Expenditure Panel Survey 2002, was used. The financial burden of prescription drugs was measured by the out-of-pocket expenditure and proportion. In the market model (utilization adjustment)., utilization was measured at the annual aggregate level by the total number of prescription drugs, the average refills and the average quantity per prescription drug. In the egalitarian model (need adjustment)., health was measured by 15 chronic and costly diseases and the SF-12. Individuals 65 years or older were included. Nationally representative estimates were calculated. Raw racial and ethnic disparities were observed in the bivariate analyses between non-Hispanic whites and Hispanics in the out-of-pocket expenditure and proportion, and between non-Hispanic whites and non-Hispanic blacks in the out-of-pocket proportion. However, these disparities disappeared after controlling for utilization or health needs. Insurance status contributed the most to the disparities in the financial burden of prescription drugs. In conclusion, The disparities in the financial burden of prescription drugs between non-Hispanic elderly whites and Hispanics may be attributable to differences in utilization patterns. However, whether health disparities contribute to disparities in the financial burden of prescription drugs requires studies of specific diseases.

Get full access to this article

View all access options for this article.

References

AHRQ. (1999). Medical Expenditure Panel Survey. Rockville, MD: Agency for Healthcare Research and Quality, Center for Cost and Financing Studies.

AHRQ. (2002). Medical Expenditure Panel Survey, from http://www.meps.ahrq.gov/.

Bearison

D. J.

, Minian

, & Granowetter

(2002). Medical management of asthma and folk medicine in a Hispanic community. Journal of Pediatric Psychology, 27(4)., 385–392.

Borders

T. F.

(2004). Rural community-dwelling elders' reports of access to care: are there Hispanic versus non-Hispanic white disparities? Journal of Rural Health, 20(3)., 210–220.

Briesacher

, Limcangco

, & Gaskin

(2003). Racial and ethnic disparities in prescription coverage and medication use. Health Care Financial Review, 25(2)., 63–76.

Cromwell

, McCall

N. T.

, Burton

, & Urato

(2005). Race/ethnic disparities in utilization of lifesaving technologies by Medicare ischemic heart disease beneficiaries. Medical Care, 43(4)., 330–337.

Danzon

P. M.

, & Pauly

M. V.

(2001). Insurance and new technology: from hospital to drugstore. Health Affairs (Millwood)., 20(5)., 86–100.

Daumit

G. L.

, Hermann

J. A.

, Coresh

, & Powe

N. R.

(1999). Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Annals of Internal Medicine, 130(3)., 173–182.

Dole

E. J.

, Rhyne

R. L.

, Zeilmann

C. A.

, Skipper

B. J.

, McCabe

M. L.

, & Dog

T. L.

(2000). The influence of ethnicity on use of herbal remedies in elderly Hispanics and non-Hispanic whites. Journal of the American Pharmacological Association (Wash)., 40(3)., 359–365.

10.

Fitzpatrick

A. L.

, Powe

N. R.

, Cooper

L. S.

, Ives

D. G.

, & Robbins

J. A.

(2004). Barriers to health care access among the elderly and who perceives them. American Journal of Public Health, 94(10)., 1788–1794.

11.

Groeneveld

P. W.

, Laufer

S. B.

, & Garber

A. M.

(2005). Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Medical Care, 43(4)., 320–329.

12.

Hurley

J. S.

, Frost

E. J.

, Trinkaus

K. M.

, Buatti

M. C.

, & Emmett

K. E.

(1998). Relationship of compliance with hormone replacement therapy to short- term healthcare utilization in a managed care population. American Journal of Managed Care, 4(12)., 1691–1698.

13.

Lai

Y. H.

, Keefe

F. J.

, Sun

W. Z.

, Tsai

L. Y.

, Cheng

P. L.

, Chiou

J. F.

, . (2002). Relationship between pain-specific beliefs and adherence to analgesic regimens in Taiwanese cancer patients: a preliminary study. Journal of Pain Symptom Management, 24(4)., 415–423.

14.

Opolka

J. L.

, Rascati

K. L.

, Brown

C. M.

, & Gibson

P. J.

(2004). Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine. Psychiatric Service, 55(2)., 151–156.

15.

Poisal

J. A.

, & Murray

(2001). Growing differences between Medicare beneficiaries with and without drug coverage. Health Affair (Millwood)., 20(2)., 74–85.

16.

Rohrer

J. E.

, Kruse

, Borders

, & Kupersmith

(2003). Realized access to physician services among the elderly in West Texas. Journal of Rural Health, 19(1)., 72–78.

17.

Schectman

J. M.

, Bovbjerg

V. E.

, & Voss

J. D.

(2002). Predictors of medication-refill adherence in an indigent rural population. Medical Care, 40(12)., 1294–1300.

18.

Schore

, Brown

, & Lavin

(2003). Racial disparities in prescription drug use among dually eligible beneficiaries. Health Care Financial Review, 25(2)., 77–90.

19.

Sharma

, Liu

, & Wang

(2003). Drug coverage, utilization, and spending by Medicare beneficiaries with heart disease. Health Care Financial Review, 24(3), 139–156.

20.

Siegal

B. R.

, & Greenstein

S. M.

(1997). Postrenal transplant compliance from the perspective of African- Americans, Hispanic-Americans, and Anglo-Americans. Advancements in Renal Replacement Therapy, 4(1)., 46–54.

21.

Smith

, Heffler

S. K.

, Calfo

, Clemens

, Freeland

, Seifert

M. L.

, . (1999). National health projections through 2008. Health Care Financial Review, 21(2)., 211–237.

22.

K. T.

(2003). Financial disparities in prescription drug use between elderly and nonelderly Americans. Health Affair (Millwood)., 22(5)., 210–221.

23.

K. T.

, Moloney

, & Phillips

(2003). Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension. American Journal of Managed Care, 9(8)., 529–536.

24.

K. T.

, Smith

S. R.

, & Borders

T. F.

(2003). Access to prescription drugs among noninstitutionalized elderly people in west Texas. American Journal of Health Systems Pharma, 60(7)., 675–682.